OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Sonidegib as a Locally Advanced Basal Cell Carcinoma Therapy in Real-life Clinical Setting: A National Multicentre Study
O.M. Moreno-Arrones, S. Béa-Ardebol, Fátima Mayo‐Martínez, et al.
Actas Dermo-Sifiliográficas (2023) Vol. 114, Iss. 7, pp. 565-571
Open Access | Times Cited: 11
O.M. Moreno-Arrones, S. Béa-Ardebol, Fátima Mayo‐Martínez, et al.
Actas Dermo-Sifiliográficas (2023) Vol. 114, Iss. 7, pp. 565-571
Open Access | Times Cited: 11
Showing 11 citing articles:
Real-world experience with vismodegib and sonidegib in advanced basal cell carcinoma: a multicenter Italian study
Mario Valenti, S. Di Giulio, Andrea Carugno, et al.
Dermatology Reports (2025)
Open Access | Times Cited: 1
Mario Valenti, S. Di Giulio, Andrea Carugno, et al.
Dermatology Reports (2025)
Open Access | Times Cited: 1
Sonidegib in Locally Advanced Basal Cell Carcinoma: A Monocentric Retrospective Experience and a Review of Published Real-Life Data
Gianluca Nazzaro, Valentina Benzecry, Maria A. Mattioli, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3621-3621
Open Access | Times Cited: 12
Gianluca Nazzaro, Valentina Benzecry, Maria A. Mattioli, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3621-3621
Open Access | Times Cited: 12
Lokal fortgeschrittene Basalzellkarzinome sind mit charakteristischer Darmmikrobiom‐Signatur assoziiert
Óscar M. Moreno‐Arrones, Sonia Beá‐Ardébol, Sagrario Galiano‐Mejías, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2025) Vol. 23, Iss. 1, pp. 104-107
Closed Access
Óscar M. Moreno‐Arrones, Sonia Beá‐Ardébol, Sagrario Galiano‐Mejías, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2025) Vol. 23, Iss. 1, pp. 104-107
Closed Access
Secondary resistance to sonidegib is rare in locally advanced basal cell carcinoma
Eva Muñoz‐Couselo, Carola Berking, Jean François Baurain, et al.
Journal of the European Academy of Dermatology and Venereology (2025)
Open Access
Eva Muñoz‐Couselo, Carola Berking, Jean François Baurain, et al.
Journal of the European Academy of Dermatology and Venereology (2025)
Open Access
Locally advanced basal cell carcinoma in real life: analysis of a cohort of 452 patients treated with systemic therapy from the CARADERM database.
F. Herms, Mourad Djermane, M. Beylot-Barry, et al.
EJC Skin Cancer (2025), pp. 100729-100729
Open Access
F. Herms, Mourad Djermane, M. Beylot-Barry, et al.
EJC Skin Cancer (2025), pp. 100729-100729
Open Access
Multicenter Retrospective Andalusian Study of the Use of Sonidegib for the Treatment of Local Advanced Basal Cell Carcinoma in Real Clinical Practice
Ricardo Ruíz‐Villaverde, Enrique Herrera‐Acosta, Andrés Ruiz de Casas, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 17, pp. 5631-5631
Open Access | Times Cited: 5
Ricardo Ruíz‐Villaverde, Enrique Herrera‐Acosta, Andrés Ruiz de Casas, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 17, pp. 5631-5631
Open Access | Times Cited: 5
Novel paradigm of therapeutic intervention for skin cancer: challenges and opportunities
Modassir Nasim, Mariya Khan, Rabea Parveen, et al.
Future Journal of Pharmaceutical Sciences (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Modassir Nasim, Mariya Khan, Rabea Parveen, et al.
Future Journal of Pharmaceutical Sciences (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Understanding and managing locally advanced basal cell carcinoma: insights into pathogenesis, therapeutic strategies, and the role of hedgehog pathway inhibitors
Marta Cebolla-Verdugo, Carlos Llamas‐Segura, Juan Pablo Velasco‐Amador, et al.
Italian Journal of Dermatology and Venereology (2024) Vol. 159, Iss. 5
Closed Access | Times Cited: 1
Marta Cebolla-Verdugo, Carlos Llamas‐Segura, Juan Pablo Velasco‐Amador, et al.
Italian Journal of Dermatology and Venereology (2024) Vol. 159, Iss. 5
Closed Access | Times Cited: 1
Complete response of metastatic cutaneous squamous cell carcinoma and multiple locally advanced basal cell carcinomas with concomitant pembrolizumab and sonidegib therapy
Carlos González‐Cruz, Eva Muñoz‐Couselo, Carolina Ortiz, et al.
JAAD Case Reports (2024) Vol. 46, pp. 67-69
Open Access
Carlos González‐Cruz, Eva Muñoz‐Couselo, Carolina Ortiz, et al.
JAAD Case Reports (2024) Vol. 46, pp. 67-69
Open Access
Locally advanced basal cell carcinoma associated with distinct gut microbiome signature
Óscar M. Moreno‐Arrones, Sonia Beá‐Ardébol, Sagrario Galiano‐Mejías, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024)
Closed Access
Óscar M. Moreno‐Arrones, Sonia Beá‐Ardébol, Sagrario Galiano‐Mejías, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024)
Closed Access
Interim analysis of the multinational, post-authorization safety study (NISSO) to assess the long-term safety of sonidegib in patients with locally advanced basal cell carcinoma
Ralf Gutzmer, Ulrike Leiter, Peter Möhr, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
Ralf Gutzmer, Ulrike Leiter, Peter Möhr, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
